Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
High Resolution Steady State Blood Volume Maps in Glioblastoma Using MRI - A Multicenter Study
Sponsor: OHSU Knight Cancer Institute
Listed as NCT02359097, this NA trial focuses on Glioblastoma and remains completed. Sponsored by OHSU Knight Cancer Institute, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
-
Jun 2021 — Apr 2022 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Jun 2021 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Feb 2020 — Aug 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2020 [monthly]
Recruiting NA
-
Jul 2017 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jul 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- OHSU Knight Cancer Institute
- Oregon Health and Science University
For direct contact, visit the study record on ClinicalTrials.gov .